Welcome to LookChem.com Sign In|Join Free

CAS

  • or
8-Bromo-7-chloro-2-methoxy-[1,5]naphthyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

915976-85-1

Post Buying Request

915976-85-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

915976-85-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 915976-85-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,5,9,7 and 6 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 915976-85:
(8*9)+(7*1)+(6*5)+(5*9)+(4*7)+(3*6)+(2*8)+(1*5)=221
221 % 10 = 1
So 915976-85-1 is a valid CAS Registry Number.

915976-85-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 8-bromo-7-chloro-2-methoxy-1,5-naphthyridine

1.2 Other means of identification

Product number -
Other names 8-bromo-7-chloro-2-(methyloxy)-[1,5]naphthyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:915976-85-1 SDS

915976-85-1Relevant articles and documents

SIX-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND AND USES THEREOF SERVING AS PROTEIN RECEPTOR KINASE INHIBITOR

-

Paragraph 0085; 0098-0100; 0106; 0116-0118, (2021/09/24)

Provided are a preparation and applications of a six-membered fused with six-membered heterocyclic compound, specifically, provided in the present invention is a compound as represented by formula I as follows, where the definitions of the groups are as described in the description. The compound has TRK kinase inhibiting activity and can serve as a pharmaceutical composition for treating TRK dysfunction-related diseases.

BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

-

, (2013/03/26)

Novel bridged bicyclic compounds are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antibacterial agents. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating bacterial infections and associated diseases and conditions.

TRICYCLIC COMPOUNDS AS ANTIBACTERIALS

-

Page/Page column 52-53, (2008/12/08)

Tricyclic nitrogen containing compounds of formula (I) and their use as antibacterials.

HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIBACTERIALS

-

Page/Page column 40, (2008/06/13)

Tricyclic nitrogen containing compounds of formula (I) and their use as antibacterials .

TRYCLIC NITROGEN CONTAINING COMPOUNDS AND THEIR USE AS ANTIBACTERIALS

-

Page/Page column 19-20, (2008/06/13)

Tricyclic nitrogen containing compounds of formula (I) and their use as antibacterials.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 915976-85-1